Decoding the Castrate-Resistant Prostate Cancer Market: Trends, Demand Surge, and Key Player Insights
Market Overview Global Castrate-Resistant Prostate Cancer Market size and share is currently valued at USD 12.92 billion in 2024 and is anticipated to generate an estimated revenue of USD 29.79 billion by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 8.7% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2025 - 2034 Castrate-resistant prostate cancer accounts for a significant share of the global prostate cancer burden, particularly affecting older male populations. Characterized by its resistance to standard hormonal therapies, CRPC represents a major hurdle in oncology. The growing awareness about prostate cancer screening, the introduction of new biomarkers for early detection, and the increased focus on extending patient survival through innovative therapies are vital contributors to market growth. The market is segmented based on treatment type, including chemotherapy, h...